Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Identification of Adverse Risk Factors for Survival in Acquired Pure Red Cell Aplasia Receiving Immunosuppressive Therapy By the Japan PRCA2004/2006 Study and Introduction to the New Cohort Study PRCA2016

Blood (2017) 130 (Supplement 1): 4954.

https://doi.org/10.1182/blood.V130.Suppl_1.4954.4954

Published: 2017

Journal Articles

The Prognostic Impact Of Complex Gene Mutation In The Intermediate Risk Karyotype Acute Myeloid Leukemia

Satoshi Wakita, MD, PhD, Hiroki Yamaguchi, MD, PhD, Takeshi Ryotokuji, MD, Tuneaki Hirakawa, MD, PhD, Ikuko Omori, Tomoaki Kitano, Kunihito Arai, Yoshio Mitamura, Fumiko Kosaka, Kazuo Dan, MD, PhD, Koiti Inokuchi, MD, PhD

Blood (2013) 122 (21): 1418.

https://doi.org/10.1182/blood.V122.21.1418.1418

Published: 2013

Journal Articles

Inhibition Of S100A6 Induces Graft Versus Leukemia Effects In MLL/AF4-Positive ALL In Human PBMC-SCID Mice

Hayato Tamai, MD, Hiroki Yamaguchi, MD, PhD, Kazuo Dan, MD, PhD, Koiti Inokuchi, MD, PhD

Blood (2013) 122 (21): 2016.

https://doi.org/10.1182/blood.V122.21.2016.2016

Published: 2013

Journal Articles

AAV8 vector expressing IL24 efficiently suppresses tumor growth mediated by specific mechanisms in MLL/AF4 -positive ALL model mice

Hayato Tamai, Koichi Miyake, Hiroki Yamaguchi, Miyuki Takatori, Kazuo Dan, Koiti Inokuchi, Takashi Shimada

Blood (2012) 119 (1): 64–71.

https://doi.org/10.1182/blood-2011-05-354050

Published: 2012

Includes: Supplemental data

Journal Articles

B7-H1 Molecules on Myeloma Cells Induce Aggressive Cell Behavior

Hideto Tamura, MD, PhD, Mariko Ishibashi, PhD, Taishi Yamashita, PhD, Asaka Kondo, MD, PhD, Namiko Okuyama, MD, Hideya Hyodo, MD, PhD, Yasuko Hamada, MD, Kazuo Dan, MD, PhD, Lieping Chen, MD, PhD, Kiyoyuki Ogata

Blood (2011) 118 (21): 474.

https://doi.org/10.1182/blood.V118.21.474.474

Published: 2011

Journal Articles

The Clinical Features and Prognostic Impact of DNMT3A Gene Mutation in Japanese Patients with De Novo AML

Takeshi Ryotokuji, MD, Hiroki Yamaguchi, MD, PhD, Ikuko Omori, Tuneaki Hirakawa, MD, PhD, Satoshi Wakita, MD, Tomoaki Kitano, Yoshio Mitamura, Fumiko Kosaka, Takashi Shimada, MD, PhD, Koiti Inokuchi, MD, PhD, Kazuo Dan, MD, PhD

Blood (2011) 118 (21): 2537.

https://doi.org/10.1182/blood.V118.21.2537.2537

Published: 2011

Journal Articles

Gene Mutations in Paired Initial Presentation and Relapse Samples From Acute Myeloid Leukemia Patients,

Satoshi Wakita, MD, Hiroki Yamaguchi, MD, PhD, Yoshio Mitamura, Fumiko Kosaka, Takashi Shimada, MD, PhD, Koiti Inokuchi, MD, PhD, Kazuo Dan, MD, PhD

Blood (2011) 118 (21): 3592.

https://doi.org/10.1182/blood.V118.21.3592.3592

Published: 2011

Journal Articles

Seven-Year Follow-up of Patients Receiving Imatinib for the Treatment of Chronic Myelogenous Leukemia by the TARGET System

Tetsuzo Tauchi, M.D., Masahiro Kizaki, M.D., Shinichiro Okamoto, M.D., Hideo Tanaka, M.D., Mitsune Tanimoto, M.D., Koiti Inokuchi, M.D., Tohru Murayama, M.D., Yoshio Saburi, M.D., Masayuki Hino, M.D., Mitsuru Tsudo, M.D., Taizo Shimomura, M.D., Yasushi Isobe, M.D., Kazuo Oshimi, MD, Kazuo Dan, M.D., Kazuma Ohyashiki, M.D., Yasuo Ikeda, M.D.

Blood (2010) 116 (21): 2287.

https://doi.org/10.1182/blood.V116.21.2287.2287

Published: 2010

Journal Articles

MLL/AF4 Positive Acute Lymphoblastic Leukemia Has Resistance to Tumor Necrosis Factor-Alpha Caused by up-Regration of S100A6

Hayato Tamai, MD, Koichi Miyake, MD, PhD, Hiroki Yamaguchi, MD, PhD, Masahiro Okabe, MD, Kazuo Dan, MD, PhD, Koiti Inokuchi, PhD, MD, Takashi Shimada, MD, PHD

Blood (2010) 116 (21): 2477.

https://doi.org/10.1182/blood.V116.21.2477.2477

Published: 2010

Journal Articles

The Activated K-RAS Protein Accelerates Human Derived-MLL/AF4 Induced Leukemo-Lymphomogenicity In Transgenic Mice Model

Hayato Tamai, MD, Koichi Miyake, MD, PhD, Miyuki Takatori, Noriko Miyake, Hiroki Yamaguchi, MD, PhD, Kazuo Dan, MD, PhD, Takashi Shimada, MD, PHD, Koiti Inokuchi, PhD, MD

Blood (2010) 116 (21): 61.

https://doi.org/10.1182/blood.V116.21.61.61

Published: 2010

Journal Articles

Interferon-γ and tumor necrosis factor-α induce an immunoinhibitory molecule, B7-H1, via nuclear factor-κB activation in blasts in myelodysplastic syndromes

Asaka Kondo, Taishi Yamashita, Hideto Tamura, Wanhong Zhao, Takashi Tsuji, Masumi Shimizu, Eiji Shinya, Hidemi Takahashi, Koji Tamada, Lieping Chen, Kazuo Dan, Kiyoyuki Ogata

Blood (2010) 116 (7): 1124–1131.

https://doi.org/10.1182/blood-2009-12-255125

Published: 2010

Includes: Supplemental data

Journal Articles

Highly Sensitive Quenching Probe (QProbe) Method Is Useful to Detect c-Kit Mutation and to Predict Relapse of t(8;21)(q22;q22) Acute Myeloid Leukemia.

Satoshi Wakita, Hiroki Yamaguchi, Yoshio Mitamura, Fumiko Kosaka, Koiti Inokuchi, Kazuo Dan

Blood (2009) 114 (22): 2646.

https://doi.org/10.1182/blood.V114.22.2646.2646

Published: 2009

Journal Articles

Interferon-γ and Tumor Necrosis Factor-α Induce An Immunoinhibitory Molecule, B7-H1, Via NfκB Activation in Blasts of Myelodysplastic Syndromes.

Asaka Kondo, Hideto Tamura, Taishi Yamashita, Chikako Sato, Zhao Wanhong, Takashi Tsuji, Eiji Shinya, Hidemi Takahashi, Koji Tamada, Lieping Chen, Kazuo Dan, Kiyoyuki Ogata

Blood (2009) 114 (22): 2766.

https://doi.org/10.1182/blood.V114.22.2766.2766

Published: 2009

Journal Articles

Prognostic Significance of WT1 mRNA and Anti-WT1 Antibody Levels in Peripheral Blood in Patients with Myelodysplastic Syndromes.

Hideto Tamura, MD, PhD, Kazuo Dan, Norio Yokose, Rika Iwakiri, Masatsugu Ohta, Hisashi Sakamaki, Kaoru Tohyama, Kondo Asaka, Hideya Hyodo, Kyoko Nakamura, Taishi Yamashita, Olga A Elisseeva, Yoshihiro Oka, Yusuke Oji, Haruo Sugiyama, Kiyoyuki Ogata

Blood (2009) 114 (22): 3821.

https://doi.org/10.1182/blood.V114.22.3821.3821

Published: 2009

Journal Articles

Establishment and Characterization of A New Leukemia Mouse Model Induced by MLL/AF4 Fusion Protein.

Hayato Tamai, Koichi Miyake, Noriko Miyake, Hiroki Yamaguchi, Kazuo Dan, Takashi Shimada, Koiti Inokuchi

Blood (2009) 114 (22): 3573.

https://doi.org/10.1182/blood.V114.22.3573.3573

Published: 2009

Journal Articles

Expression and Function of B7.2 and B7-H2 Molecules on Myeloma Cells

Taishi Yamashita, Hideto Tamura, MD, PhD, Chikako Sato, Asaka Kondo, Eiji Shinya, Hidemi Takahashi, Lieping Chen, Takashi Tsuji, Kazuo Dan, Kiyoyuki Ogata, MD, PhD

Blood (2008) 112 (11): 2722.

https://doi.org/10.1182/blood.V112.11.2722.2722

Published: 2008

Journal Articles

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes: A Prospective Validation Study in Low-Risk Patients with Normal Karyotype

Kiyoyuki Ogata, Matteo G. Della Porta, Luca Malcovati, Cristina Picone, Norio Yokose, Akira Matsuda, Taishi Yamashita, Hideto Tamura, Junichi Tsukada, Kazuo Dan, Mario Cazzola

Blood (2008) 112 (11): 3634.

https://doi.org/10.1182/blood.V112.11.3634.3634

Published: 2008

Journal Articles

Expression of WT-1 mRNA in Peripheral Blood from Myelodysplastic Syndromes

Hideto Tamura, MD, PhD, Kazuo Dan, Norio Yokose, Rika Iwakiri, Masatsugu Ohta, Hisashi Sakamaki, MD, PhD, Kaoru Tohyama, Asaka Kondo, Kyoko Nakamura, Taishi Yamashita, Takashi Tsuji, Kiyoyuki Ogata, MD, PhD

Blood (2008) 112 (11): 3637.

https://doi.org/10.1182/blood.V112.11.3637.3637

Published: 2008

Journal Articles

Importance of Relative Dose Intensity for Survival in Diffuse Large B-Cell Lymphoma Patients Treated with CHOP-Like Regimen

Tsuneaki Hirakawa, Hiroki Yamaguchi, Seiji Gomi, Norio Yokose, Koiti Inokuchi, Kazuo Dan

Blood (2008) 112 (11): 3605.

https://doi.org/10.1182/blood.V112.11.3605.3605

Published: 2008

Journal Articles

Identification of the SBDS Gene Mutation in Japanese Patients with Bone Marrow Failure Syndrome

Hiroki Yamaguchi, Junko Takeuchi, Hayato Tamai, Yoshio Mitamura, Fumiko Kosaka, Kazuo Dan, Koiti Inokuchi

Blood (2008) 112 (11): 4117.

https://doi.org/10.1182/blood.V112.11.4117.4117

Published: 2008

NARROW

Identification of Adverse Risk Factors for Survival in Acquired Pure Red Cell Aplasia Receiving Immunosuppressive Therapy By the Japan PRCA2004/2006 Study and Introduction to the New Cohort Study PRCA2016

The Prognostic Impact Of Complex Gene Mutation In The Intermediate Risk Karyotype Acute Myeloid Leukemia

Inhibition Of S100A6 Induces Graft Versus Leukemia Effects In MLL/AF4-Positive ALL In Human PBMC-SCID Mice

AAV8 vector expressing IL24 efficiently suppresses tumor growth mediated by specific mechanisms in MLL/AF4 -positive ALL model mice

B7-H1 Molecules on Myeloma Cells Induce Aggressive Cell Behavior

The Clinical Features and Prognostic Impact of DNMT3A Gene Mutation in Japanese Patients with De Novo AML

Gene Mutations in Paired Initial Presentation and Relapse Samples From Acute Myeloid Leukemia Patients,

Seven-Year Follow-up of Patients Receiving Imatinib for the Treatment of Chronic Myelogenous Leukemia by the TARGET System

MLL/AF4 Positive Acute Lymphoblastic Leukemia Has Resistance to Tumor Necrosis Factor-Alpha Caused by up-Regration of S100A6

The Activated K-RAS Protein Accelerates Human Derived-MLL/AF4 Induced Leukemo-Lymphomogenicity In Transgenic Mice Model

Interferon-γ and tumor necrosis factor-α induce an immunoinhibitory molecule, B7-H1, via nuclear factor-κB activation in blasts in myelodysplastic syndromes

Highly Sensitive Quenching Probe (QProbe) Method Is Useful to Detect c-Kit Mutation and to Predict Relapse of t(8;21)(q22;q22) Acute Myeloid Leukemia.

Interferon-γ and Tumor Necrosis Factor-α Induce An Immunoinhibitory Molecule, B7-H1, Via NfκB Activation in Blasts of Myelodysplastic Syndromes.

Prognostic Significance of WT1 mRNA and Anti-WT1 Antibody Levels in Peripheral Blood in Patients with Myelodysplastic Syndromes.

Establishment and Characterization of A New Leukemia Mouse Model Induced by MLL/AF4 Fusion Protein.

Expression and Function of B7.2 and B7-H2 Molecules on Myeloma Cells

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes: A Prospective Validation Study in Low-Risk Patients with Normal Karyotype

Expression of WT-1 mRNA in Peripheral Blood from Myelodysplastic Syndromes

Importance of Relative Dose Intensity for Survival in Diffuse Large B-Cell Lymphoma Patients Treated with CHOP-Like Regimen

Identification of the SBDS Gene Mutation in Japanese Patients with Bone Marrow Failure Syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only